NSC |
Compound |
Enrichment |
Correlation |
NSC 740 |
Methotrexate |
0.0414190425892865 |
0.33456019 |
NSC 740024 |
4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine |
0.0414190425892865 |
0.26229481 |
NSC 743528 |
Null |
0.0414190425892865 |
0.32712334 |
NSC 754245 |
5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione |
0.0414190425892865 |
0.27016832 |
NSC 762559 |
Null |
0.0414190425892865 |
-0.19630103 |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0414190425892865 |
0.19706014 |
NSC 109834 |
Null |
0.0414190425892871 |
0.28511695 |
NSC 109154 |
Null |
0.0421163101172308 |
0.46829464 |
NSC 323241 |
3-Azabicyclo[3.2.2]nonane-3-carboselenoic acid, [1-(2-pyridinyl)ethylidene]hydrazide |
0.0421163101172308 |
0.28400411 |
NSC 374998 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyrimidinyl)ethylidene] hydrazide |
0.0421163101172308 |
0.48868933 |